In 2017, China's top 20 western medicine export companies were born

[China Pharmaceutical network enterprise news] the author understands that in 2017, China's pharmaceutical exports reached US $3.456 billion, an increase of 8.32% year on year Recently, the list of top 20 enterprises in China's export of Western medicine preparations was released in 2017 According to the China Business Industry Research Institute, the top 20 enterprises include Zhejiang Huahai Pharmaceutical Co., Ltd., Guilin South pharmaceutical Co., Ltd., Jiangsu Hengrui Pharmaceutical Co., Ltd., Shiyao group, Qilu Pharmaceutical Co., Ltd., Shanghai Pharmaceutical Holding Co., Ltd., Zhejiang Haizheng Pharmaceutical Co., Ltd., etc With the changes in the growth point of the international market, the export of R & D innovative pharmaceutical enterprises has gradually become the main driving force for the export of pharmaceutical preparations, and the export of foreign pharmaceutical enterprises has grown significantly, these pharmaceutical enterprises have maintained a rapid growth, and laid the foundation for stabilizing the domestic market and opening up the overseas market The following selected some enterprises for a brief introduction Zhejiang Huahai Pharmaceutical Co., Ltd ranking: 1 as a leading international pharmaceutical enterprise in China, Huahai pharmaceutical industry is a pharmaceutical enterprise that has passed the quality certification of FDA preparations in the United States and has its own anda number At the same time, Huahai Pharmaceutical Co., Ltd is also a Chinese pharmaceutical enterprise that has achieved large-scale sales of preparations in the United States, which has established the quality image of Chinese pharmaceutical in the world pharmaceutical market At present, Huahai pharmaceutical products cover cardiovascular, psychiatric, antiviral, antihistamines and other fields It is the world's major manufacturer of cardiovascular and psychiatric health care products It is reported that in 2017, the sales volume of major domestic varieties of Huahai pharmaceutical, including paroxetine, losartan, irbesartan hydrochlorothiazide, irbesartan and fosinopril, increased by 24.8%, 84.91%, 152.54%, 58.68% and 76.38% respectively Ranking of Ruiyang Pharmaceutical Co., Ltd.: 4 Ruiyang Pharmaceutical Co., Ltd is a domestic powder injection manufacturer in Shandong Province, a key high-tech enterprise of the state and a backbone enterprise of the achievement industrial base of the National 863 plan In 2010, the company's main product, mezlocillin sodium for injection and its compound preparation won the second prize of national science and technology progress award At present, the products of Ruiyang pharmaceutical, such as Gegen Tang granules and Houpu exhaust mixture, are also recognized as "national key new products" The sub packaging of powder injection preparation, extraction of traditional Chinese medicine and synthesis technology of cephalosporins are all up to the advanced level in China Jiangsu Kaiyuan pharmaceutical and Chemical Co., Ltd ranking: 8 Kaiyuan pharmaceutical is mainly engaged in R & D, production and trade in pharmaceutical and chemical industry Kaiyuan pharmaceutical has established its own production base of finished drugs, APIs and intermediates with the support of industry; set up a research and development center with advanced instruments and equipment and experienced technicians with the support of R & D; promote development with the support of trade, and adhere to the customer-oriented principle while based on the business development At the beginning of its establishment, Kaiyuan pharmaceutical has obtained business licenses for research and development and technology transfer of pharmaceutical and chemical products, import and export of various commodities and technologies, and domestic trade of pharmaceutical and chemical products In order to strictly manage and standardize the operation of hazardous chemicals, the company obtained the hazardous chemicals operation license in early 2009 through training and certification Shandong Jingwei Pharmaceutical Co., Ltd ranked: 13 Jingwei pharmaceutical is a high-tech enterprise, listed products include respiratory drugs, central nervous system drugs, skin and mucous membrane drugs The scope of drug production is aerosol, aerosol, inhalation powder, inhalation liquid, tablet, capsule, granule, ointment, enema, raw material and so on The author understands that Jingwei pharmaceutical's quality system has been GMP certified by the Australian drug administration (TGA) for many times, and its products are exported to more than 50 countries such as Australia and New Zealand The company also has a professional R & D team of more than 140 people, and has a provincial inhalation preparation engineering laboratory recognized by the government, which consists of a preparation research room, a quality research room, a synthesis research room, a clinical research room, and a preparation and API pilot plant meeting different scale pilot test conditions Suzhou Dongrui Pharmaceutical Co., Ltd ranking: 19 Dongrui pharmaceutical is mainly engaged in the development, manufacturing and sales of cephalosporin antibiotics and system specialty drugs The cephalosporin antibiotic products of Toray pharmaceutical include intermediates, APIs and powder injections; the specialized drugs cover cardiovascular system, anti hepatitis B virus, anti allergy, digestive system, urinary system and endocrine system, and the dosage forms include tablets, capsules and granules At present, Dongrui pharmaceutical has established the brand of "an" series cardiovascular drugs, and established Dongrui pharmaceutical R & D center in 2002 The author understands that the current business sales of Dongrui pharmaceutical cover wholesale, retail, import and export and clinical promotion modes respectively, which has a good ability to quickly cover new products to hospitals Attachment: list of top 20 Chinese Western medicine exports in 2017